Literature DB >> 7391945

Rectal bioavailability of lidocaine in rats: absence of significant first-pass elimination.

A G de Boer, D D Breimer, J Pronk, J M Gubbens-Stibbe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7391945     DOI： 10.1002/jps.2600690716

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  6 in total

1.  Avoidance of first-pass metabolism of propranolol after rectal administration as a function of the absorption site.

Authors:  K Iwamoto; J Watanabe
Journal:  Pharm Res       Date:  1985-01       Impact factor: 4.200

Review 2.  Rectal drug administration: clinical pharmacokinetic considerations.

Authors:  A G de Boer; F Moolenaar; L G de Leede; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

3.  Pharmacokinetics of heptacaine, a novel potent local anaesthetic agent, after rectal administration to rats.

Authors:  V Faberová; M Durisová; T Trnovec; D Divisová
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Jul-Sep       Impact factor: 2.441

4.  Avoidance of "first-pass" elimination of rectally administered propranolol in relation to the site of absorption in rats.

Authors:  L G de Leede; A G de Boer; J P Havermans; D D Breimer
Journal:  Pharm Res       Date:  1984-07       Impact factor: 4.200

5.  Site specific rectal drug administration in man with an osmotic system: influence on "first-pass" elimination of lidocaine.

Authors:  L G de Leede; A G de Boer; C D Feijen; D D Breimer
Journal:  Pharm Res       Date:  1984-05       Impact factor: 4.200

Review 6.  Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations.

Authors:  Melissa Kirkby; Aaron R J Hutton; Ryan F Donnelly
Journal:  Pharm Res       Date:  2020-06-02       Impact factor: 4.200
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.